Medicare Enrolled

Dr. Emily Marx, M.D.

Internal Medicine · San Antonio, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
19272 STONE OAK PKWY, San Antonio, TX 78258
2102658851
In practice since 2008 (18 years)
NPI: 1144491002 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Marx from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Marx? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Marx

Dr. Emily Marx is an internal medicine specialist in San Antonio, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Marx performed 124,631 Medicare services across 4,064 unique beneficiaries.

Between the years covered by Open Payments, Dr. Marx received a total of $14,203 from 43 pharmaceutical and/or device companies across 798 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Marx is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 0% volume in TX $14,203 industry payments

Medicare Practice Summary

Medicare Utilization ↗
124,631
Medicare services
Top 0% in TX for internal medicine
4,064
Unique beneficiaries
$13
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~6,924 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Certolizumab injection (Cimzia) 35,000 $4 $19
Golimumab infusion (Simponi Aria) 30,695 $11 $48
Abatacept infusion (Orencia) 17,025 $33 $134
Tocilizumab injection (Actemra) 13,427 $4 $17
Romosozumab injection (Evenity) for osteoporosis 8,400 $8 $28
Infliximab infusion (Remicade) 4,045 $26 $114
Injection, infliximab-abda, biosimilar, (renflexis), 10 mg 3,400 $31 $119
Denosumab injection (Prolia/Xgeva) 2,400 $18 $42
Joint lubricant injection (Synvisc) 1,536 $7 $25
Office visit, established patient (30-39 min) 1,031 $89 $253
Comprehensive metabolic blood panel 1,003 $10 $26
Complete blood count (CBC) with differential 966 $8 $20
C-reactive protein test (inflammation marker) 887 $5 $14
Sed rate test (inflammation marker) 700 $3 $6
Measurement of antibody for assessment of autoimmune disorder, any method 656 $17 $44
Administration of chemotherapy into vein, 1 hour or less 624 $99 $399
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle 279 $55 $222
Administration of chemotherapy into vein, each additional hour 177 $21 $85
Analysis of substance using immunoassay technique, multiple step method 152 $11 $28
Injection, methylprednisolone acetate, 40 mg 143 $6 $15
Cardiolipin antibody (tissue antibody) measurement 132 $25 $63
Measurement of complement (immune system proteins), antigen, 128 $12 $29
Vitamin D level test 124 $29 $72
Beta 2 glycoprotein 1 antibody (autoantibody) measurement 123 $25 $63
Measurement of dna antibody, native or double stranded 117 $13 $35
Measurement of dna antibody, single stranded 117 $12 $29
Screening test for autoimmune disorder 116 $12 $29
Vitamin B-12 level test 99 $15 $38
Aspiration and/or injection of fluid large joint using ultrasound guidance 98 $89 $273
Measurement of antibody for rheumatoid arthritis assessment 83 $13 $32
Uric acid level test 82 $4 $12
Rheumatoid factor level 81 $6 $15
Measurement of substance using immunoassay technique 80 $17 $39
Injection, methylprednisolone acetate, 80 mg 77 $9 $28
Injection, methylprednisolone sodium succinate, up to 40 mg 71 $3 $13
Injection of additional new drug or substance into vein 59 $12 $47
Flu vaccine administration 54 $30 $61
Office visit, established patient, complex (40-54 min) 53 $138 $331
Office visit, established patient (20-29 min) 48 $61 $166
Joint injection, major joint 47 $50 $128
Drug injection, under skin or into muscle 46 $10 $42
Flu vaccine, quadrivalent 45 $74 $75
Injection, methylprednisolone acetate, 20 mg 42 $3 $4
Iron binding capacity test 41 $8 $22
Ferritin level test (iron stores) 38 $13 $35
New patient office visit (45-59 min) 36 $124 $497
Creatine kinase (cardiac enzyme) level, total 20 $6 $17
Aspiration and/or injection of fluid from small joint 17 $41 $96
Injection into tendon or ligament 11 $45 $116
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
41.5% high complexity
52.8% medium
5.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$14,203
Total received (2018-2024)
Avg $2,029/year across 7 years
Top 6% in TX for internal medicine
43
Companies
798
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$14,016 (98.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$186 (1.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,545
2023
$2,345
2022
$1,673
2021
$1,780
2020
$1,339
2019
$2,663
2018
$2,857

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$2,188
Novartis Pharmaceuticals Corporation
$1,772
UCB, Inc.
$1,063
Janssen Biotech, Inc.
$1,016
Mallinckrodt Hospital Products Inc.
$862
Horizon Therapeutics plc
$832
E.R. Squibb & Sons, L.L.C.
$829
Lilly USA, LLC
$789
PFIZER INC.
$541
GENZYME CORPORATION
$488
GlaxoSmithKline, LLC.
$487
Genentech USA, Inc.
$340
Radius Health, Inc.
$334
Horizon Pharma plc
$297
Flexion Therapeutics, Inc.
$249
Aurinia Pharma U.S., Inc.
$214
Actelion Pharmaceuticals US, Inc.
$209
Ferring Pharmaceuticals Inc.
$206
Merck Sharp & Dohme Corporation
$191
Celgene Corporation
$180
AstraZeneca Pharmaceuticals LP
$152
ANI Pharmaceuticals, Inc.
$147
Pacira Therapeutics, Inc.
$114
SANOFI-AVENTIS U.S. LLC
$113
Mallinckrodt Enterprises LLC
$88
Antares Pharma, Inc.
$85
Hikma Pharmaceuticals USA
$69
Takeda Pharmaceuticals U.S.A., Inc.
$56
Exeltis, USA Inc.
$46
Mallinckrodt LLC
$31
MEDEXUS PHARMA, INC.
$23
Ultragenyx Pharmaceutical Inc.
$22
Octapharma USA, Inc.
$20
Sandoz Inc.
$20
Fresenius Kabi USA, LLC
$19
FIDIA PHARMA USA INC.
$17
Ironwood Pharmaceuticals, Inc
$16
SCILEX PHARMACEUTICALS INC.
$14
Endo Pharmaceuticals Inc.
$13
Kiniksa Pharmaceuticals, Ltd.
$13
Boehringer Ingelheim Pharmaceuticals, Inc.
$13
Janssen Scientific Affairs, LLC
$11
MEDAC PHARMA, INC.
$11
Top 3 companies account for 35.4% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · AREXVY · AVSOLA · Actemra · Arcalyst · BELSOMRA · BENLYSTA · COSENTYX · CUVITRU · Cimzia · Crysvita · DUZALLO · EUFLEXXA · EVENITY · Enbrel · FORTEO · HYRIMOZ · Hymovis · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · LEMTRADA · LUPKYNIS · LYRICA · Mitigare · NASCOBAL · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OPSUMIT · ORENCIA · OTREXUP · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · Rasuvo · Rituxan · SAPHNELO · SHINGRIX · SIMPONI · SIMPONI ARIA · SYNVISC-ONE · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · UPTRAVI · Uloric · XELJANZ · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 6% for internal medicine in TX.

Equivalent to $11 per 100 Medicare services performed
Looking for an internal medicine specialist in San Antonio?
Compare internal medicine physicians in the San Antonio area by procedure volume, costs, and industry payment transparency.
Browse internal medicine physicians nearby

Geographic Context

Internal medicine physicians within 10 mi
1,149
Per 100K population
56.4
County median income
$70,571
Nearest hospital
SOUTH TEXAS SPINE AND SURGICAL HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Marx is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), with low-engagement industry engagement in the top 6% of TX peers, with 18 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Marx experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Marx performed 35,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Marx receive payments from pharmaceutical companies?
Yes. Dr. Marx received a total of $14,203 from 43 companies across 798 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Marx's costs compare to other internal medicine physicians in San Antonio?
Dr. Marx's average Medicare payment per service is $13. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Marx) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →